Receptor Proteins for Nongenomic Actions of Thyroid Hormone
Genomic actions of thyroid hormone require the intranuclear binding by nuclear thyroid hormone receptors (TRs) of 3,5,3'-triiodo-L-thyronine (T3). Nongenomic actions of the hormone have been described that are initiated at the plasma membrane, in cytoplasm or in the mitochondrion. These are complex processes associated with maintenance of the cytoskeleton, control of cell respiration, cell proliferation—including tumor cell proliferation and angiogenesis—and nervous system function. We briefly review here the nature of the proteins which are now appreciated to initiate nongenomic actions of the hormone when they bind T3 or L-thyroxine (T4). These receptor proteins for nongenomic effects include truncated isoforms of TR.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2015 |
---|---|
Erschienen: |
2015 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Immunology, endocrine & metabolic agents in medicinal chemistry - 15(2015), 1, Seite 94-97 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Davis, Paul J. [VerfasserIn] |
---|
Links: |
---|
BKL: |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
OLC1986720993 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | OLC1986720993 | ||
003 | DE-627 | ||
005 | 20230518124703.0 | ||
007 | cr uuu---uuuuu | ||
008 | 170131s2015 xx |||||o 00| ||eng c | ||
028 | 5 | 2 | |a fidpha_zeitschriften_20170130.pp |
035 | |a (DE-627)OLC1986720993 | ||
035 | |a (DE-599)GBVOLC1986720993 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |
084 | |a PHARM |2 fid | ||
084 | |a 44.40 |2 bkl | ||
100 | 1 | |a Davis, Paul J. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Receptor Proteins for Nongenomic Actions of Thyroid Hormone |
264 | 1 | |c 2015 | |
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Genomic actions of thyroid hormone require the intranuclear binding by nuclear thyroid hormone receptors (TRs) of 3,5,3'-triiodo-L-thyronine (T3). Nongenomic actions of the hormone have been described that are initiated at the plasma membrane, in cytoplasm or in the mitochondrion. These are complex processes associated with maintenance of the cytoskeleton, control of cell respiration, cell proliferation—including tumor cell proliferation and angiogenesis—and nervous system function. We briefly review here the nature of the proteins which are now appreciated to initiate nongenomic actions of the hormone when they bind T3 or L-thyroxine (T4). These receptor proteins for nongenomic effects include truncated isoforms of TR | ||
700 | 1 | |a Leonard, Jack L. |e verfasserin |4 aut | |
700 | 1 | |a Lin, Hung-Yun |e verfasserin |4 aut | |
700 | 1 | |a Incerpi, Sandra |e verfasserin |4 aut | |
700 | 1 | |a Luidens, Mary K. |e verfasserin |4 aut | |
700 | 1 | |a Tang, Heng-Yuan |e verfasserin |4 aut | |
700 | 1 | |a Mousa, Shaker A. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Immunology, endocrine & metabolic agents in medicinal chemistry |d San Francisco, Calif. : Bentham Science Publ., 2006 |g 15(2015), 1, Seite 94-97 |w (DE-627)507526643 |w (DE-600)2221719-8 |w (DE-576)435514261 |x 1871-5222 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2015 |g number:1 |g pages:94-97 |
856 | 4 | 0 | |u http://www.eurekaselect.com/openurl/content.php?genre=article&issn=1871-5222&volume=15&issue=1&spage=94 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
912 | |a FID-PHARM | ||
912 | |a SSG-OLC-PHA | ||
912 | |a SSG-OLC-DE-84 | ||
912 | |a SSG-OPC-PHA | ||
912 | |a GBV_ILN_20 | ||
936 | b | k | |a 44.40 |q AVZ |
951 | |a AR | ||
952 | |d 15 |j 2015 |e 1 |h 94-97 |